Literature DB >> 22743157

The relationship between posttraumatic stress disorder, mood states, functional status, and quality of life in oncology outpatients.

Jeffrey I Gold1, Marilyn K Douglas, Mary Laudon Thomas, Janette E Elliott, Stephen M Rao, Christine Miaskowski.   

Abstract

CONTEXT: Oncology patients are at risk for developing posttraumatic stress disorder (PTSD) and other comorbid mood states, which are associated with decreases in functional status and quality of life (QOL). However, few studies have investigated the relationship between PTSD, other mood states, functional status, and QOL in oncology outpatients.
OBJECTIVES: This study had four aims: 1) determine the percentages of patients with PTSD and partial PTSD; 2) evaluate for differences in demographic and clinical characteristics among patients with PTSD, partial PTSD, and no PTSD; 3) evaluate for differences in mood states, functional status, and QOL among the three PTSD groups; and 4) evaluate whether demographic and disease characteristics were predictors of PTSD.
METHODS: As part of a larger clinical trial that evaluated the effects of a cognitive-behavioral intervention on cancer pain management, 289 adult oncology patients (M(age)=61.3, SD=11.6) completed self-report measures that assessed PTSD, other mood states, functional status, and QOL.
RESULTS: Forty-five percent of the sample met the diagnostic criteria for PTSD (n=78) and partial PTSD (n=53) and were younger than those with no PTSD. Patients with PTSD had a significantly lower Karnofsky Performance Status, shorter time since diagnosis, higher ratings of mood disturbance, lower ratings of functional status, and lower QOL than patients with no PTSD. A lower Karnofsky Performance Status, fewer months since diagnosis, and presence of bone metastases predicted a higher likelihood of being classified as having PTSD.
CONCLUSION: Early identification and interventions may mediate the onset of psychological distress and improve health outcomes.
Copyright © 2012 U.S. Cancer Pain Relief Committee. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22743157     DOI: 10.1016/j.jpainsymman.2011.10.014

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Evaluation of coping as a mediator of the relationship between stressful life events and cancer-related distress.

Authors:  Dale J Langford; Bruce Cooper; Steven Paul; Janice Humphreys; Carolyn Keagy; Yvette P Conley; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Christine Miaskowski; Laura B Dunn
Journal:  Health Psychol       Date:  2017-08-21       Impact factor: 4.267

Review 2.  Psychological and behavioral approaches to cancer pain management.

Authors:  Karen L Syrjala; Mark P Jensen; M Elena Mendoza; Jean C Yi; Hannah M Fisher; Francis J Keefe
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

3.  Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening.

Authors:  Seema Malhotra Thekdi; Kathrin Milbury; Amy Spelman; Qi Wei; Christopher Wood; Surena F Matin; Nizar Tannir; Eric Jonasch; Louis Pisters; Lorenzo Cohen
Journal:  Psychooncology       Date:  2015-02-17       Impact factor: 3.894

4.  Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors.

Authors:  Ahrang Jung; Jamie L Crandell; Matthew E Nielsen; Sophia K Smith; Ashley Leak Bryant; Deborah K Mayer
Journal:  Support Care Cancer       Date:  2022-04-18       Impact factor: 3.603

5.  Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital.

Authors:  Florence Joly; Olivier Rigal; Lydia Guittet; Sophie Lefèvre-Arbogast; Jean-Michel Grellard; Giulia Binarelli; Marie Lange; Chantal Rieux; Marie Fernette; Laure Tron; François Gernier; Romain Travers; Adeline Morel; Doriane Richard; Bénédicte Griffon; Alexandra Leconte; Etienne Bastien; Florian Quilan; Louis-Ferdinand Pépin; Fabrice Jardin; Marianne Leheurteur; Bénédicte Clarisse; Justine Lequesne; Audrey Faveyrial
Journal:  Cancer       Date:  2021-08-16       Impact factor: 6.921

6.  Post-traumatic stress disorder symptoms in non-muscle-invasive bladder cancer survivors: A population-based study.

Authors:  Ahrang Jung; Jamie L Crandell; Matthew E Nielsen; Deborah K Mayer; Sophia K Smith
Journal:  Urol Oncol       Date:  2020-12-08       Impact factor: 2.954

Review 7.  Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function.

Authors:  Lauren C Brown; Amy R Murphy; Chloe S Lalonde; Preeti D Subhedar; Andrew H Miller; Jennifer S Stevens
Journal:  Cancer       Date:  2020-05-06       Impact factor: 6.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.